New donation to the research of MEF2C Syndrome

Last December 11 we made a new donation of €18,000 to the research of MEF2C Syndrome that Dr. Lipton is developing in California. We make the transfers with more and more hope because we see our objective closer. Now we have already seen one of the treatments in mice published in a prestigious journal, now when he talks about a clinical trial he raises it as something close … now we are more hopeful than ever and we fight with even more strength. And all this is thanks to your support and solidarity. That is why we want to share this news with you and we want to thank you for being there and contributing doing your part.

Moreover, if you look at the data of the transfer, this time there is a small change, because it is not addressed to the Scintillon Institute. Now Dr Lipton is part of the “The Scripps Research Institute (TSRI)” which has one of the best departments in the world in the discovery of new medicines. In fact, it has recently been ranked number one in a global ranking of new drug and patent development. This is one of the reasons that is making the research advance more quickly, and provide more optimism both to the doctor and to us about the proximity of the desired treatment.

THANK YOU FROM OUR HEART!

#juntosmiramosalfuturo     (#WeLookForwardTogether)
#loimposiblesolocuestamás          (#TheImpossibleIsJustMoreDemanding)